디지털 치료 개인화 플랫폼 시장 예측(-2034년) : 제품별, 컴포넌트별, 기술별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Digital Therapeutics Personalization Platforms Market is accounted for $2.5 billion in 2026 and is expected to reach $8.9 billion by 2034 growing at a CAGR of 17.2% during the forecast period. Digital therapeutics personalization platforms are software-based solutions that deliver evidence-based therapeutic interventions to patients, customized to their individual health profiles, behaviors, and preferences. These platforms use AI, machine learning, and real-time data from wearables and sensors to adapt treatment plans dynamically, ensuring optimal efficacy and patient engagement. They are designed to treat, manage, or prevent a broad spectrum of medical conditions, from mental health to chronic diseases.

Market Dynamics:

Driver:

Shift Towards Patient-Centric Precision Medicine

The growing shift from a one-size-fits-all approach to patient-centric, precision medicine is a key driver for platforms that can personalize treatment based on an individual's unique genetic, behavioral, and environmental data. Digital therapeutics platforms enable healthcare providers to deliver tailored interventions that are more effective and have better adherence. The increasing focus on outcomes-based care and the proven clinical efficacy of personalized therapies are accelerating the adoption of these platforms.

Restraint:

Clinical Evidence and Regulatory Standardization

The need for robust clinical evidence to demonstrate the efficacy and safety of personalized digital therapeutics remains a major challenge, requiring expensive and lengthy randomized controlled trials. The lack of standardized regulatory pathways for AI-driven adaptive therapies creates uncertainty for developers and can delay market entry. This need for rigorous clinical validation can be a significant barrier, especially for smaller companies, limiting the pace of innovation.

Opportunity:

Integration with Wearable Devices

The integration of personalization platforms with wearable devices and remote monitoring technologies offers a significant opportunity to continuously collect patient data and adapt therapy in real-time. This allows for dynamic, responsive interventions that can be adjusted based on immediate changes in the patient's condition. The growing consumer adoption of wearables and the development of advanced sensors are creating new avenues for data-driven personalization and market growth.

Threat:

Data Privacy and Security Concerns

The reliance on large amounts of sensitive patient health data makes digital therapeutics platforms a prime target for cyberattacks and data breaches, which could lead to significant financial losses and erosion of patient trust. The complexity of complying with diverse global data privacy regulations like HIPAA and GDPR adds to the compliance burden. Any major privacy scandal could severely undermine the credibility of the entire industry and limit adoption.

Covid-19 Impact:

The pandemic significantly accelerated the adoption of digital health and remote care, boosting interest in digital therapeutics. During the mid-pandemic period, the need for accessible and contactless mental health support drove the adoption of these platforms. Post-pandemic, the market is characterized by sustained growth, with a focus on integrating these solutions into mainstream healthcare delivery.

The chronic disease platforms segment is expected to be the largest during the forecast period

The chronic disease platforms segment is expected to account for the largest market share during the forecast period, due to the high prevalence of chronic conditions like diabetes and cardiovascular disease and the need for long-term, personalized management strategies. This segment benefits from the ability to integrate with various monitoring devices and provide continuous, data-driven support, which improves patient outcomes and reduces healthcare costs. The proven ROI of chronic disease management and the increasing focus on value-based care further secure its leading position.

The software segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the software segment is predicted to witness the highest growth rate, driven by the continuous innovation in AI algorithms and the development of sophisticated, user-friendly applications for both patients and clinicians. The growing adoption of cloud-based and AI-powered personalization engines is making these platforms more scalable and accessible. The rapid expansion of telehealth and remote monitoring is fueling demand for integrated software solutions, which in turn accelerates the growth of this key segment.

Region with largest share:

During the forecast period, North America is expected to hold the largest share of the Digital Therapeutics Personalization Platforms Market, driven by advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of digital health technologies. The United States leads the regional market with favorable reimbursement policies, strong regulatory support for digital therapeutics, and increasing integration of AI-powered personalized treatment platforms. The presence of major technology providers, growing consumer awareness, and rising demand for remote patient management further reinforce the region's market leadership.

Region with highest CAGR:

Over the forecast period, Asia Pacific is anticipated to register the highest CAGR in the Digital Therapeutics Personalization Platforms Market, supported by rapid healthcare digitalization, expanding smartphone and internet penetration, and increasing prevalence of chronic diseases. Countries including China, India, Japan, and South Korea are investing heavily in digital health initiatives and telemedicine infrastructure. Rising healthcare accessibility, supportive government policies, growing adoption of personalized care solutions, and increasing awareness of digital therapeutics are expected to accelerate market growth across the region.

Key players in the market

Some of the key players in Digital Therapeutics Personalization Platforms Market include Pear Therapeutics, Click Therapeutics, Akili, Inc., Onduo LLC, Livongo Health, Omada Health, Hinge Health, Better Therapeutics, DarioHealth Corp., Kaia Health, Propeller Health, Roche Holding AG, Medtronic plc, ResMed Inc., Philips Healthcare and Oracle Health.

Key Developments:

In July 2026, Omada Health launched a new digital therapeutics platform for chronic disease management, integrating real-time wearable data with AI-powered personalization to deliver adaptive treatment recommendations, improve patient engagement, and support long-term health outcomes.

In June 2026, Pear Therapeutics announced a partnership with a health insurance provider to expand access to its personalized digital therapeutics for mental health, improving reimbursement coverage, patient accessibility, treatment adherence, and clinical outcomes across broader populations.

In May 2026, Click Therapeutics introduced a new platform for personalized behavioral therapy, utilizing machine learning to continuously adapt interventions based on patient progress, enhancing treatment effectiveness, engagement, personalized care delivery, and long-term therapeutic outcomes.

Products Covered:

• AI Personalization Platforms
• Behavioral Therapy Platforms
• Chronic Disease Platforms
• Mental Health Platforms
• Remote Monitoring Platforms
• Adaptive Therapy Platforms
• Digital Coaching Platforms

Components Covered:

• Software
• Services
• Analytics Engines
• Patient Applications
• Clinical Dashboards
• Integration Platforms
• Cloud Infrastructure

Technologies Covered:

• Artificial Intelligence
• Machine Learning
• Predictive Analytics
• Natural Language Processing
• Behavioral Analytics
• Wearable Integration
• Cloud Computing

Applications Covered:

• Diabetes Management
• Mental Health
• Cardiovascular Care
• Respiratory Care
• Neurological Disorders
• Obesity Management
• Sleep Disorders

End Users Covered:

• Hospitals
• Clinics
• Patients
• Health Insurance Providers
• Pharmaceutical Companies
• Employers
• Research Organizations

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Digital Therapeutics Personalization Platforms Market, By Product

• 5.1 AI Personalization Platforms
• 5.2 Behavioral Therapy Platforms
• 5.3 Chronic Disease Platforms
• 5.4 Mental Health Platforms
• 5.5 Remote Monitoring Platforms
• 5.6 Adaptive Therapy Platforms
• 5.7 Digital Coaching Platforms

6 Global Digital Therapeutics Personalization Platforms Market, By Component

• 6.1 Software
• 6.2 Services
• 6.3 Analytics Engines
• 6.4 Patient Applications
• 6.5 Clinical Dashboards
• 6.6 Integration Platforms
• 6.7 Cloud Infrastructure

7 Global Digital Therapeutics Personalization Platforms Market, By Technology

• 7.1 Artificial Intelligence
• 7.2 Machine Learning
• 7.3 Predictive Analytics
• 7.4 Natural Language Processing
• 7.5 Behavioral Analytics
• 7.6 Wearable Integration
• 7.7 Cloud Computing

8 Global Digital Therapeutics Personalization Platforms Market, By Application

• 8.1 Diabetes Management
• 8.2 Mental Health
• 8.3 Cardiovascular Care
• 8.4 Respiratory Care
• 8.5 Neurological Disorders
• 8.6 Obesity Management
• 8.7 Sleep Disorders

9 Global Digital Therapeutics Personalization Platforms Market, By End User

• 9.1 Hospitals
• 9.2 Clinics
• 9.3 Patients
• 9.4 Health Insurance Providers
• 9.5 Pharmaceutical Companies
• 9.6 Employers
• 9.7 Research Organizations

10 Global Digital Therapeutics Personalization Platforms Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Pear Therapeutics
• 13.2 Click Therapeutics
• 13.3 Akili, Inc.
• 13.4 Onduo LLC
• 13.5 Livongo Health
• 13.6 Omada Health
• 13.7 Hinge Health
• 13.8 Better Therapeutics
• 13.9 DarioHealth Corp.
• 13.10 Kaia Health
• 13.11 Propeller Health
• 13.12 Roche Holding AG
• 13.13 Medtronic plc
• 13.14 ResMed Inc.
• 13.15 Philips Healthcare
• 13.16 Oracle Health